Dermatitis, Eczematous Completed Phase 3 Trials for Clobetasone (DB13158)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01567995Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and SafetyTreatment